Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Gideon Blumstein

Orthopaedic Surgery of the Spine Marina Del Rey, CA Medical Doctor

NPI 1164819207 CMS profile 9337844

4640 Admiralty Way Ste 600, Marina Del Rey, CA 90292

Open in the dashboard

General payments

$9,885

53 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gideon Blumstein of Marina Del Rey, CA is reported in the CMS Open Payments database as having received $9,885 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 46th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,699 10
2024 General $5,010 11
2023 General $977 15
2022 General $632 5
2021 General $1,566 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gideon Blumstein
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Gideon Blumstein were reported at $1,699. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Gideon Blumstein Orthopaedic Surgery of the Spine median Middle half National median
2019 $0 $2,106 $337–$18,608 $163
2020 $0 $1,213 $156–$15,082 $114
2021 $1,566 $1,834 $271–$15,617 $132
2022 $632 $2,015 $320–$17,036 $149
2023 $977 $1,925 $336–$14,599 $160
2024 $5,010 $2,110 $341–$12,483 $164
2025 $1,699 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Joimax, Inc. $4,464 3 payments
  2. Medtronic, Inc. $1,138 14 payments
  3. Curiteva, Inc. $600 2 payments
  4. NuVasive, Inc. $598 8 payments
  5. Synthes GmbH $541 1 payment
  6. Globus Medical, Inc. $476 8 payments
  7. Stryker Corporation $398 1 payment
  8. DePuy Synthes Sales Inc. $369 3 payments
  9. Alphatec Spine, Inc $243 2 payments
  10. SI-BONE, Inc. $163 2 payments
  11. Other $896 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,479 45 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,675 1 payment
  3. Travel and Lodging $1,731 7 payments
Products named General payments · program years 2021–2025
  1. Xvision $550 5 payments
  2. EVEREST SPINAL SYSTEM $398 1 payment
  3. XLIF $383 5 payments
  4. FIBERGRAFT BG Morsels $268 2 payments
  5. Direct Look $234 1 payment
  6. DIVERGENCE-L ANTERIOR/OBLIQUE LUMBAR FUSION SYSTEM $194 1 payment
  7. Simplify Cervical Artificial Disc $190 3 payments
  8. Other - Miscellaneous $164 1 payment
  9. IFUSE IMPLANT $163 2 payments
  10. Axis Spine Technologies ALIF Implant $150 1 payment
  11. Other $2,148 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

68

Median for Orthopedic Surgery: 203

Drug cost

$234

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 24 $157
Meloxicam Generic 31 $59
Tramadol Hcl Generic 13 $17

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$40,633

Medicare's payments for the services billed

Medicare patients

145

Average age 75

Services billed

254

69 women, 76 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 43%
Depression 29%
Diabetes 28%
Osteoporosis 27%
Heart failure 21%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record